Impact of Self-Monitoring Blood Glucose on Glycemic Control among Insulin-Treated Patients with Diabetes Mellitus in Northeastern Tanzania: A Randomized Controlled Trial
Not Applicable
- Conditions
- Diabetes Mellitus
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 80
Inclusion Criteria
a)DM patients aged above 18 years
b)Patients diagnosed with either T1DM or T2DM, and receiving insulin treatment at the time of enrolment, which was started at least 3 months before enrolment
c)Patients with HbA1c levels higher than 8%
d)Patients who could read or write, or had a reliable guardian who could do so
Exclusion Criteria
a)Patients with DM above 18 years of age with HbA1c levels higher than 8% who were pregnant
b)Patients with a glomerular filtration rate below 15ml/min
c)Hemoglobin less than 9g/dL
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The primary endpoint was the reduction of HbA1c, after applying the intervention, by at least 1.2% after 12 weeks.
- Secondary Outcome Measures
Name Time Method The secondary endpoint was the adherence to the intervention, structured SMBG, and its acceptability, as well as the facilitators and barriers associated with the use of the intervention, SMBG, and ability to self-manage DM, which was analyzed after the completion of the intervention which was 12 weeks.